Clinical Social Workers in West Valley, UT Accepting Medicare
24 Clinical Social Workers found. Showing 21 - 24
 Ms. Deborah Ann Davis, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5698 Glen Eagle Dr, West Valley, UT 84128 Phone: 801-969-4181 |
Dorothea Clayton, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3940 W 4100 S, West Valley, UT 84120 Phone: 801-712-0571 Fax: 801-561-4776 |
Ruth Sarahi Aguirre, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5698 Glen Eagle Dr, West Valley, UT 84128 Phone: 801-969-4181 |
Amber Lingard, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5698 W Glen Eagle Dr, West Valley, UT 84128 Phone: 801-969-4181 Fax: 801-969-1291 |
News Archive
Evidence-based interventions provide promising strategies for reducing racial, ethnic health disparities
Evidence-based interventions at the local and national levels provide promising strategies for reducing racial and ethnic health disparities related to HIV infection rates, immunization coverage, motor vehicle injuries and deaths, and smoking, according to a new report by the CDC's Office of Minority Health and Health Equity.
Daily exercise lessens harmful physiological effects of short-term overeating, inactivity, says study
Daily exercise lessens many of the harmful physiological effects of short-term overeating and inactivity, shows a new study [published 15 December] in The Journal of Physiology, which is well timed with the Christmas holiday approaching.
AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
GeneNews granted second U.S. patent for Sentinel Principle technology
GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."
'Brain advantages' for effective business leadership
Business leaders are in charge-of people, of budgets, of production lines. Most leaders also believe that they are in charge of their greatest resource-their own brain. But how true is that? The more we understand about how the brain works, the clearer it becomes that often our brain kicks in before we do.
› Verified 4 days ago
- 1
- 2(current)